• LAST PRICE
    11.5100
  • TODAY'S CHANGE (%)
    Trending Up1.0450 (9.9857%)
  • Bid / Lots
    11.3100/ 1
  • Ask / Lots
    11.5400/ 1
  • Open / Previous Close
    10.8800 / 10.4650
  • Day Range
    Low 10.7500
    High 11.7656
  • 52 Week Range
    Low 8.2600
    High 30.4000
  • Volume
    186,001
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 10.465
TimeVolumeGYRE
09:32 ET519710.88
09:33 ET171410.945
09:35 ET356610.775
09:37 ET126810.85
09:39 ET519011.01
09:42 ET30010.96
09:44 ET523211.17
09:46 ET145111.2
09:48 ET50011.2375
09:50 ET10011.19
09:51 ET130111.15
09:53 ET141511.08
09:55 ET240011.1575
09:57 ET271911.225
10:00 ET221311.175
10:02 ET110011.16
10:04 ET832511.25
10:08 ET150011.245
10:09 ET132211.16
10:11 ET269011.05
10:15 ET20111.05
10:18 ET202710.99
10:20 ET20011.05
10:24 ET241111.05
10:26 ET30011.2298
10:27 ET120011.16
10:29 ET299511.19
10:31 ET15411.07
10:36 ET110011.1579
10:38 ET162011.1666
10:42 ET10011.12
10:47 ET661311.14
11:05 ET70011.18
11:07 ET10011.19
11:09 ET10011.1918
11:12 ET66911.14
11:16 ET122011.1925
11:18 ET20011.225
11:20 ET100011.225
11:21 ET18811.2
11:25 ET30011.22
11:27 ET10011.2
11:34 ET510611.2175
11:36 ET10011.265
11:39 ET10011.33
11:41 ET10011.19
11:48 ET218011.2
11:52 ET18411.3182
11:54 ET43511.294
11:56 ET10011.235
11:59 ET20011.23
12:01 ET162911.25
12:21 ET10011.25
12:28 ET417711.47
12:32 ET60011.41
12:37 ET997511.495
12:44 ET62011.36
12:46 ET30011.47
12:51 ET90011.48
12:53 ET30011.48
12:55 ET131111.47
01:00 ET74011.48
01:04 ET79011.475
01:06 ET20011.48
01:09 ET100011.54
01:15 ET30011.52
01:26 ET10011.55
01:31 ET20011.54
01:36 ET355411.54
01:38 ET96311.7656
01:40 ET389211.596
01:42 ET103811.48
01:47 ET222611.462068
01:49 ET10011.445
01:56 ET30011.36
02:12 ET10011.36
02:14 ET319011.4
02:16 ET10011.44
02:21 ET133011.4
02:23 ET10011.37
02:25 ET20011.375
02:32 ET20011.46
02:34 ET10011.4431
02:36 ET10011.4471
02:38 ET65911.35
02:43 ET10011.4198
02:50 ET89011.405
02:54 ET30011.43
03:01 ET78811.45
03:08 ET77111.45
03:12 ET10011.475
03:17 ET10011.47
03:19 ET10011.44
03:24 ET49611.47
03:30 ET40011.48
03:32 ET49611.48
03:35 ET10011.46
03:37 ET19811.48
03:44 ET20011.49
03:46 ET24211.49
03:48 ET15811.48
03:51 ET10011.5399
03:53 ET50011.41
03:55 ET140011.435
03:57 ET166311.45
04:00 ET677811.51
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesGYRE
Gyre Therapeutics Inc
1.1B
-50.5x
---
United StatesVIR
Vir Biotechnology Inc
1.1B
-2.1x
---
United StatesZYME
Zymeworks Inc
981.5M
-9.5x
---
United StatesARDX
Ardelyx Inc
1.4B
-18.4x
---
United StatesTRDA
Entrada Therapeutics Inc
807.9M
13.5x
---
United StatesIMTX
Immatics NV
936.9M
-12.4x
---
As of 2024-12-07

Company Information

Gyre Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is engaged in the research, development, manufacturing, and commercialization of drugs for organ fibrosis. It is primarily focused on the development and commercialization of F351 (Hydronidone) for the treatment of Nonalcoholic Steatohepatitis Treatment (NASH)-associated fibrosis. The Company is also advancing a diverse pipeline in the China through its indirect controlling interest in Gyre Pharmaceuticals, including ETUARY therapeutic expansions, F573, F528, and F230. The Company operates through two segments: Gyre Pharmaceuticals, and Gyre after the Contributions. The Gyre Pharmaceuticals has one major commercial drug product, ETUARY, and several product candidates in pre-clinical and clinical development. Gyre is a biopharmaceutical company focused on the development and commercialization of F351 for the treatment of non-alcoholic steatohepatitis-associated liver fibrosis in the United States.

Contact Information

Headquarters
12770 High Bluff Drive, Suite 150SAN DIEGO, CA, United States 92130
Phone
619-949-3681
Fax
302-636-5454

Executives

Non-Executive Chairman of the Board
Ying Luo
President, Director
Songjiang Ma
Chief Executive Officer, Director
Han Ying
Interim Chief Financial Officer
Ruoyu Chen
Chief Operating Officer
Weiguo Ye

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.1B
Revenue (TTM)
$191.3M
Shares Outstanding
93.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.93
EPS
$-0.23
Book Value
$0.64
P/E Ratio
-50.5x
Price/Sales (TTM)
5.6
Price/Cash Flow (TTM)
---
Operating Margin
-24.92%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.